- Smokers’ Immune Genetic Feature Found to Lower Lung Cancer Risk
- Study of 27 Million People: Cardiovascular Disease Patients May Be More Prone to Cancer
- Unlocking the Mystery of Fatigue: Acetylcholine Therapy for Post-COVID-19 Syndrome
- Study Finds Closing Toilet Lid Does Not Reduce Virus Spread
- The century-old BCG vaccine may be the nemesis of stubborn liver cancer
- New developments in kidney cancer treatment
The structure and function of adenovirus core protein
The structure and function of adenovirus core protein. Adenovirus was first isolated from human proliferating glands in 1953 and can infect humans and livestock. Certain types of human adenovirus can induce tumors in newborn hamsters, which is important in medicine and veterinary medicine.
Adenovirus has 11 structural proteins (PI~PX, plus TP). Among them, PV, PVII, TP (terminal protein) and PX (enzyme protein) four polypeptides/proteins and DNA together form the core of the virus. The main core protein is PVII, which wraps viral DNA.
Next, we will briefly introduce the structure and function of several of these proteins:
pVII is a highly basic protein, rich in arginine (23%) and alanine (19%) residues. Approximately 46% of pVII amino acids are positively charged or highly cationic, which makes them attractive to the negatively charged phosphate backbone of DNA.
Functionally, pVII interacts with DNA and cellular proteins to regulate the life cycle of the virus. pVII is a functional analog of cellular histone (H) and has been widely accepted. H4 is one of the subunits of histones, which is acetylated and phosphorylated. Although the H4 subunit and pVII do not have much structural similarities, both proteins contain a non-random distribution of basic residues and appear to be acetylated and phosphorylated, and the mass ratio of protein to DNA is 1 :1. Interestingly, pVII mimics cellular protamine in function, which is an arginine-rich nucleoprotein that replaces histones during spermatogenesis to condense sperm head DNA. Unlike protamine, protein VII interacts with nucleosomes but cannot replace histones in nucleosomes. Recent reports indicate that pVII may be indirectly involved in the early stages of virus-cell interaction.
pV is the second most abundant core protein. However, relative to the most abundant core protein, pVII, the variable relative concentrations of pV are reported as 1:6 and 1:3.5, respectively. And pV interacts with other capsid proteins and acts as a bridge between the virus core and the virus capsid.
The highly basic N-terminus of pV interacts with genomic DNA. The pV linked to each unit of the DNA-pVII hexamer may contribute to the condensation of the viral genome. In addition, the interaction between pV and pIVa2 (a role in DNA encapsidation) suggests that pV may also play a role in viral DNA encapsidation.
In addition, pV interacts with the non-structural proteins 33K and 100K in infected cells, indicating that it has a potential role in other stages of virus replication. pV also interacts with the structural proteins penton base and pIII a, showing the complexity of pV viral protein interaction.
The IVa2 (pIVa2) protein of adenovirus is transcribed from complementary DNA strands through alternate splicing. The expression of IVa2 mRNA appears to be up-regulated by the human antigen R (HuR) protein. Initially, the pIVa2 transcription start site of pIVa2 and the cell transcription inhibitor (RF) binding site overlapped. Due to the association of the pIVa2 promoter sequence with the transcription repressor (RF), the expression of pIVa2 is delayed compared with other early proteins other than the pIX and E2 proteins. However, once the DNA is replicated, the pIVa2 promoter is activated, and transcription of pIVa2 begins.
Functionally, first of all, pIVa2 acts as a transactivator and activates the main late promoter (MLP) through the downstream binding element (DE). The downstream binding element (DE) contains two main binding sites, called DE1 and DE2a, respectively. And DE2b. The protein pIVa2 is a component of DEF-A and DEF-B, acts as a positive transcription factor, and interacts with the DE element of MLP. Second, pIVa2 plays a role in adenovirus DNA packaging. As a homodimer or a complex with virus p22K, pIVa2 alone interacts with the CG nucleotides of the A repeat consensus sequence (5-TTTG-(N8)-CG-3) of the adenovirus DNA packaging domain located at its left end. Acts on adenovirus DNA.
Adenoviral protease (AVP) is an endopeptidase encoded by AdVs in the late stage of infection. It is a highly alkaline protein and represents a new type of cysteine protease. It specifically recognizes sequence motifs, (M/I/L)XGX-G and (M/I/L)XGG-X (where X can be any amino acid). Interestingly, AVP seems to be phosphorylated.
Approximately 7-50 copies of AVP are packaged in mature virions. The new AVP is synthesized in an inactive form, and is partially active after being packaged in immature virions and combined with viral DNA. The AVP bound to the viral DNA comes into contact with the sliding pVI and is cleaved at the N- and C-termini, releasing the 11 amino acid peptide (240-250 amino acids) cofactor pVIc. The binding of pVIc to AVP bound to viral DNA activates the protease.
Finally, the adenovirus precursor protein is located by sliding the AVP-pVIc complex along with the viral DNA in the virion. A recent study showed that the 11 amino acid pVIc can act as a molecular sled, sliding AVP together with DNA. The development and evaluation of anti-adenoviral drugs is precisely due to the unique biology of AVP and the availability of the crystal structure of active and inactive forms of AVP.
The Mu protein (pMu) encoded by the late adenovirus transcript is a highly basic protein due to the large number of arginine residues. pMu contains non-overlapping nuclear and nucleolar localization signals. In addition, pMu contains two functional consensus AVP cleavage site sequences, which are recognized by AVP to generate three fragments: (a) hydrophobic N-terminal amino acids 1–31, (b) basic central amino acids 32 to 50, and (C) C-terminal amino acids 51-79. There are about 100-300 short middle parts of 19 amino acids (the 32nd to 50th amino acids) in the mature virion.
The terminal protein (TP) encoded by the E2B region of the adenovirus genome is a non-basic core protein, which is covalently bound to each 5’end of the viral double-stranded DNA. Therefore, there are only two copies of the terminal protein in the virus particle. In addition, the precursor terminal protein contains two potential adenovirus protease cleavage sites. The terminal protein is used as a primer for DNA replication and is one of the essential proteins for viral DNA replication. In fact, both effective initiation of DNA replication and prevention of false internal initiation require terminal proteins. In addition, the terminal protein seems to protect adenovirus DNA from nuclease activity.
The picture above shows the core protein function of mammary adenovirus
In summary, the structure and function of adenovirus core protein in different stages of virus infection have been elucidated in the past ten years, including evading the virus’s innate immune response and the initial stage of virus-cell interaction (Table 1). This may be because there are more advanced technologies to explore the structure of AdV and develop more effective adenovirus vectors. Future research aimed at determining the biological functions of core protein interactions will help to provide more in-depth knowledge about the biological core proteins of adenoviruses.
(source:internet, reference only)